ɫ����

The ɫ���� Technology is at the forefront of developing technologies and solutions related to cancer detection and treatment, thanks to support from the (ARPA-H).

President Joe Biden’s Cancer Moonshot initiative aims to cut the cancer death rate by half in 25 years. Three projects connected to ɫ����, which have collectively received $119 million from ARPA-H, are doing just that.

With a grant worth up to $50 million, ɫ���� will lead development of a new generation of cancer tests capable of detecting multiple types of tumors earlier than ever. Led by biomedical engineer , the project will map the unique cellular profiles of cancer cells and leverage that knowledge to build new bioengineered sensors to detect those profiles. The goal is to create a new kind of multi-cancer early detection test that would allow oncologists to start treating the tumors sooner, when they’re still small and most responsive.

The project is the third with ties to ɫ���� received in recent weeks. Professor Philip Santangelo, professor in the Wallace H. Coulter Department of Biomedical Engineering at ɫ���� and Emory University, — $24 million — for a project building a toolbox of mRNA drugs to activate or shut off specific genes to help the immune system fight cancer and other disorders.

is co-principal investigator of a $45 million Rice University-led effort to develop an implant to help the body better respond to cancer treatments. , associate professor in the School of Computer Science, is working with Hester to develop ultra-energy-efficient chips for signal processing and embedded control. Together, they will develop a robust platform that is energy-efficient enough to last for months.

“At ARPA-H, we recognize the urgency of the health challenges facing cancer patients and their families.” said ARPA-H Director Renee Wegrzyn, “and we are committed to funding truly transformative research that can improve health outcomes for everyone.”

Read more about the three projects: